NCT06233448

Brief Summary

Thorathic fluid content measurement using indirect cardiometry is required for prediction of Weaning from mechanical ventilation in cases of acute respiratory distress syndrome and its value in sucsess Weaning

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 23, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 31, 2024

Completed
10 months until next milestone

Study Start

First participant enrolled

November 20, 2024

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 2, 2024

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2024

Completed
Last Updated

December 4, 2024

Status Verified

January 1, 2024

Enrollment Period

12 days

First QC Date

January 23, 2024

Last Update Submit

December 2, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Success of weaning from mechanical ventilation

    Number of participants without artificial aids for ventilation

    48 hours

Interventions

Measurements of thorathic fluid content

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Adult Patient with ARDS on ventilator in our ICU prepared for weaning

You may qualify if:

  • patients with ARDS on ventilator for more than 48 hr. proceed for extubation

You may not qualify if:

  • heart, renal, hepatic failure Obesity , pregnancy Pneumothorax, pneumonia, hemorrhage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University hospitals

Tanta, Egypt

RECRUITING

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 23, 2024

First Posted

January 31, 2024

Study Start

November 20, 2024

Primary Completion

December 2, 2024

Study Completion

December 8, 2024

Last Updated

December 4, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations